3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Depression
4
Breast Neoplasms
4
Prostatic Neoplasms
3
Head and Neck Neoplasms
3
Triple Negative Breast Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Fatigue
2
Anxiety Disorders
2
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Smoking Cessation
1
Sleep Wake Disorders
1
Recurrence
1
Radiation Fibrosis Syndrome
1
Prostatic Hyperplasia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Patient Acceptance of Health Care
1
Pain
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Calculi
1
Inflammatory Breast Neoplasms
1
Immune Checkpoint Inhibitor-Induced Dermatitis
1
Health Education
1
Interventions
Cisplatin
18
Gemcitabine
14
Radiotherapy, Intensity-Modulated
11
Magnetic Resonance Spectroscopy
8
toripalimab
7
Specimen Handling
7
Capecitabine
7
Platinum
5
Drug Therapy
5
1,2-diaminocyclohexaneplatinum II citrate
5
camrelizumab
4
Radiotherapy
4
Nivolumab
4
spartalizumab
3
sintilimab
3
anlotinib
3
Immunoglobulin G
3
Immune Checkpoint Inhibitors
3
Docetaxel
3
Disulfides
3
atezolizumab
2
Radiation
2
Phantoms, Imaging
2
Ipilimumab
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
Bevacizumab
2
18-O-demethylcervinomycin A2
2
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
Therapeutics
×
90 days
×
Clear all
No trials found.